Viking Therapeutics, Inc.
US ˙ NasdaqCM ˙ US92686J1060

SecurityVKTX / Viking Therapeutics, Inc.
InstitutionSimplex Trading, Llc
Latest Disclosed Ownership0 shares
Latest Disclosed Value $ 0
Simplex Trading, Llc ownership in VKTX / Viking Therapeutics, Inc.

On February 11, 2026 - Simplex Trading, Llc filed a 13F-HR form disclosing ownership of 0 shares of Viking Therapeutics, Inc. (US:VKTX) valued at $0 USD as of December 31, 2025. The entity filed a previous 13F-HR on November 12, 2025 disclosing 33,354 shares of Viking Therapeutics, Inc.. The current value of the position is $0 USD.

Simplex Trading, Llc has a history of taking positions in derivatives of the underlying security (VKTX) in the form of stock options. The firm currently holds call options representing 275,600 of underlying shares valued at $8,968,024 USD and put options representing 22,900 of underlying shares valued at $745,166 USD .

Note: prior versions of this page mistakenly stated that the share values represented the number of options, not the number of underlying shares. For more information on the data backing these reports, please see the SEC document Frequently Asked Questions About Form 13F.

Institutional Ownership: 13F and NPORT Filings

The Security and Class in the table below are shown exactly as filed by the investor. We do our best to track continuity of investments through acquisitions, and this will be reflected in the table as changes in names. In addition to descriptive data, performance of the investment is shown over time. To calculate quarterly performance, we first calculate cost basis of the shares purchased during the quarter, then use that to calculate gross profit. Quarterly return is Gross Profit / Starting Portfolio value.

Note that cost basis is calculated and stored in thousands, so small quarterly changes in shares frequently result in a cost basis of zero.

Upgrade to unlock premium data and export to Excel .

Institutional Put/Call Ratios
(Premium Subscription Required)

In addition to reporting standard equity and debt issues, institutions with more than 100MM assets under management must also disclose their put and call option holdings. Since put options generally indicate negative sentiment, and call options indicate positive sentiment, we can get a sense of the overall institutional sentiment by plotting the ratio of puts to calls. The chart to the right plots the historical put/call ratio for this instrument.

Using Put/Call Ratio as an indicator of investor sentiment overcomes one of the key deficiencies of using total institutional ownership, which is that a significant amount of assets under management are invested passively to track indices. Passively-managed funds do not typically buy options, so the put/call ratio indicator more closely tracks the sentiment of actively-managed funds.

VKTX / Viking Therapeutics, Inc. Historical Put/Call Ratio
Disclosed Equity Positions (from 13F/NPORT Filings)
File
Date
Effective
Date
Form Security Class ID Avg Price
Paid (Est)
Reported
Shares
ΔShares ΔShares
(%)
Reported
Value
(x1000)
ΔValue
(%)
Alloc
(%)
ΔAlloc ΔAlloc (%) Cost Basis
(x1000)
Unrealized
Gain/Loss
(x1000)
2026-02-11 2025-12-31 13F VIKING THERAPEUTICS COM 92686J106 0 -33,354 -100.00 0 0.0000
2025-11-12 2025-09-30 13F VIKING THERAPEUTICS COM 92686J106 33,354 -70,466 -67.87 1 -100.00 0.0004
2025-08-05 2025-06-30 13F VIKING THERAPEUTICS COM 92686J106 103,820 -18,935 -15.43 3 0.00 0.0016
2025-05-12 2025-03-31 13F VIKING THERAPEUTICS COM 92686J106 122,755 90,614 281.93 3 100.00 0.0019
2025-02-11 2024-12-31 13F VIKING THERAPEUTICS COM 92686J106 32,141 -28,840 -47.29 1 -66.67 0.0007
2024-11-08 2024-09-30 13F VIKING THERAPEUTICS COM 92686J106 60,981 -20,326 -25.00 4 -25.00 0.0023
2024-07-25 2024-06-30 13F VIKING THERAPEUTICS COM 92686J106 81,307 23,308 40.19 4 0.00 0.0027
2024-04-25 2024-03-31 13F VIKING THERAPEUTICS COM 92686J106 57,999 57,999 5 0.0027
2023-08-04 2023-06-30 13F VIKING THERAPEUTICS COM 92686J106 0 -289,240 -100.00 0 -100.00
2023-04-27 2023-03-31 13F VIKING THERAPEUTICS COM 92686J106 289,240 -108,853 -27.34 5 33.33 0.0042
2023-02-02 2022-12-31 13F VIKING THERAPEUTICS COM 92686J106 398,093 372,508 1,455.96 4 -95.65 0.0041
2022-11-04 2022-09-30 13F VIKING THERAPEUTICS COM 92686J106 25,585 25,585 69 0.0001
2022-08-03 2022-06-30 13F VIKING THERAPEUTICS COM 92686J106 0 -16,133 -100.00 0 -100.00
2022-05-02 2022-03-31 13F VIKING THERAPEUTICS COM 92686J106 16,133 -14,267 -46.93 48 -65.47 0.0000
2022-02-23 2021-12-31 13F/A-1 VIKING THERAPEUTICS COM 92686J106 30,400 30,400 139 0.0001
2020-07-13 2020-06-30 13F VIKING THERAPEUTICS COM 92686J106 0 -4,799 -100.00 0 -100.00
2020-04-29 2020-03-31 13F VIKING THERAPEUTICS COM 92686J106 4,799 -3,169 -39.77 22 -65.08 0.0000
2020-02-05 2019-12-31 13F VIKING THERAPEUTICS COM 92686J106 7,968 -59,443 -88.18 63 -86.39 0.0001
2019-10-15 2019-09-30 13F VIKING THERAPEUTICS COM 92686J106 67,411 55,818 481.48 463 382.29 0.0013
2019-07-26 2019-06-30 13F VIKING THERAPEUTICS COM 92686J106 11,593 11,593 -82.80 96 -79.27 0.0003
2019-04-18 2019-03-31 13F VIKING THERAPEUTICS COM 92686J106 0 -9,534 -100.00 0 -100.00
2019-01-16 2018-12-31 13F VIKING THERAPEUTICS COM 92686J106 9,534 -52,824 -84.71 72 -93.37 0.0002
2018-10-23 2018-09-30 13F VIKING THERAPEUTICS COM 92686J106 62,358 47,404 317.00 1,086 670.21 0.0035
2018-07-30 2018-06-30 13F VIKING THERAPEUTICS COM 92686J106 14,954 7,157 91.79 141 314.71 0.0006
2018-04-26 2018-03-31 13F VIKING THERAPEUTICS COM 92686J106 7,797 7,797 34 0.0015
Disclosed Call Options
File
Date
Effective
Date
Form Security Class ID Opt Avg Share
Price
Shares ΔShares
(%)
Value
(x1000)
ΔValue
(%)
Prior Allocation
(%)
Allocation
(%)
ΔAllocation
(%)
Cost Basis
(x1000)
Profit
(x1000)
Return
(%)
2026-05-14 2026-03-31 13F VIKING THERAPEUTICS CALL Call 275,600 -57.35 8,968 -60.55 n/a n/a n/a
2026-02-11 2025-12-31 13F VIKING THERAPEUTICS CALL Call 646,200 12.95 22,733 151,453.33 n/a n/a n/a
2025-11-12 2025-09-30 13F VIKING THERAPEUTICS CALL Call 572,100 67.62 15 66.67 n/a n/a n/a
2025-08-05 2025-06-30 13F VIKING THERAPEUTICS CALL Call 341,300 19.04 9 50.00 n/a n/a n/a
2025-05-12 2025-03-31 13F VIKING THERAPEUTICS CALL Call 286,700 -30.67 7 -62.50 n/a n/a n/a
2025-02-11 2024-12-31 13F VIKING THERAPEUTICS CALL Call 413,500 -27.92 17 -55.56 n/a n/a n/a
2024-11-08 2024-09-30 13F VIKING THERAPEUTICS CALL Call 573,700 20.17 36 44.00 n/a n/a n/a
2024-07-25 2024-06-30 13F VIKING THERAPEUTICS CALL Call 477,400 -5.00 25 -39.02 n/a n/a n/a
2024-04-25 2024-03-31 13F VIKING THERAPEUTICS CALL Call 502,500 45.36 41 583.33 n/a n/a n/a
2024-02-02 2023-12-31 13F VIKING THERAPEUTICS CALL Call 345,700 -31.95 6 20.00 n/a n/a n/a
2023-11-01 2023-09-30 13F VIKING THERAPEUTICS CALL Call 508,000 -16.65 6 -44.44 n/a n/a n/a
2023-08-04 2023-06-30 13F VIKING THERAPEUTICS CALL Call 609,500 23.83 10 12.50 n/a n/a n/a
2023-04-27 2023-03-31 13F VIKING THERAPEUTICS CALL Call 492,200 165.48 8 700.00 n/a n/a n/a
2023-02-02 2022-12-31 13F VIKING THERAPEUTICS CALL Call 185,400 284.65 2 -99.24 n/a n/a n/a
2022-11-04 2022-09-30 13F VIKING THERAPEUTICS CALL Call 48,200 -62.89 131 -65.07 n/a n/a n/a
2022-08-03 2022-06-30 13F VIKING THERAPEUTICS CALL Call 129,900 617.68 375 594.44 n/a n/a n/a
2022-05-02 2022-03-31 13F VIKING THERAPEUTICS CALL Call 18,100 -68.52 54 -79.55 n/a n/a n/a
2022-02-23 2021-12-31 13F/A VIKING THERAPEUTICS CALL Call 57,500 -59.99 264 -70.96 n/a n/a n/a
2022-02-04 2021-12-31 13F VIKING THERAPEUTICS CALL Call 143,700 909 n/a n/a n/a
2021-10-28 2021-09-30 13F VIKING THERAPEUTICS CALL Call 143,700 2.86 909 8.73 n/a n/a n/a
2021-08-12 2021-06-30 13F VIKING THERAPEUTICS CALL Call 139,700 7,168.47 836 -31.19 n/a n/a n/a
2021-04-26 2021-03-31 13F VIKING THERAPEUTICS CALL Call 1,922 42.05 1,215 59.66 n/a n/a n/a
2021-02-02 2020-12-31 13F VIKING THERAPEUTICS CALL Call 1,353 -36.09 761 -38.23 n/a n/a n/a
2020-10-14 2020-09-30 13F VIKING THERAPEUTICS CALL Call 2,117 -9.84 1,232 -27.19 n/a n/a n/a
2020-07-13 2020-06-30 13F VIKING THERAPEUTICS CALL Call 2,348 5.77 1,692 63.01 n/a n/a n/a
2020-04-29 2020-03-31 13F VIKING THERAPEUTICS CALL Call 2,220 69.47 1,038 -1.14 n/a n/a n/a
2020-02-05 2019-12-31 13F VIKING THERAPEUTICS CALL Call 1,310 195.71 1,050 245.39 n/a n/a n/a
2019-10-15 2019-09-30 13F VIKING THERAPEUTICS CALL Call 443 -9.22 304 -24.94 n/a n/a n/a
2019-07-26 2019-06-30 13F VIKING THERAPEUTICS CALL Call 488 -80.27 405 -83.52 n/a n/a n/a
2019-04-18 2019-03-31 13F VIKING THERAPEUTICS CALL Call 2,473 214.63 2,458 308.99 n/a n/a n/a
2019-01-16 2018-12-31 13F VIKING THERAPEUTICS CALL Call 786 -52.31 601 -79.06 n/a n/a n/a
2018-10-23 2018-09-30 13F VIKING THERAPEUTICS CALL Call 1,648 91.18 2,870 250.86 n/a n/a n/a
2018-07-30 2018-06-30 13F VIKING THERAPEUTICS CALL Call 862 445.57 818 27,166.67 n/a n/a n/a
2018-04-26 2018-03-31 13F VIKING THERAPEUTICS CALL Call 158 3 n/a n/a n/a
Disclosed Put Options
File
Date
Effective
Date
Form Security Class ID Opt Avg Share Price Shares ΔShares
(%)
Value
(x1000)
ΔValue
(%)
Prior Allocation
(%)
Allocation
(%)
ΔAllocation
(%)
Cost Basis
(x1000)
Profit
(x1000)
Return
(%)
2026-05-14 2026-03-31 13F VIKING THERAPEUTICS PUT Put 22,900 -89.68 745 -90.46 n/a n/a n/a
2026-02-11 2025-12-31 13F VIKING THERAPEUTICS PUT Put 222,000 71.16 7,810 260,200.00 n/a n/a n/a
2025-11-12 2025-09-30 13F VIKING THERAPEUTICS PUT Put 129,700 -24.20 3 -25.00 n/a n/a n/a
2025-08-05 2025-06-30 13F VIKING THERAPEUTICS PUT Put 171,100 6.87 5 33.33 n/a n/a n/a
2025-05-12 2025-03-31 13F VIKING THERAPEUTICS PUT Put 160,100 -3.84 4 -50.00 n/a n/a n/a
2025-02-11 2024-12-31 13F VIKING THERAPEUTICS PUT Put 166,500 9.32 7 -33.33 n/a n/a n/a
2024-11-08 2024-09-30 13F VIKING THERAPEUTICS PUT Put 152,300 -39.42 10 -30.77 n/a n/a n/a
2024-07-25 2024-06-30 13F VIKING THERAPEUTICS PUT Put 251,400 -36.40 13 -59.37 n/a n/a n/a
2024-04-25 2024-03-31 13F VIKING THERAPEUTICS PUT Put 395,300 459.92 32 3,100.00 n/a n/a n/a
2024-02-02 2023-12-31 13F VIKING THERAPEUTICS PUT Put 70,600 95.03 1 n/a n/a n/a
2023-11-01 2023-09-30 13F VIKING THERAPEUTICS PUT Put 36,200 -80.91 0 -100.00 n/a n/a n/a
2023-08-04 2023-06-30 13F VIKING THERAPEUTICS PUT Put 189,600 256.39 3 n/a n/a n/a
2023-04-27 2023-03-31 13F VIKING THERAPEUTICS PUT Put 53,200 -40.09 1 n/a n/a n/a
2023-02-02 2022-12-31 13F VIKING THERAPEUTICS PUT Put 88,800 5,123.53 1 -100.00 n/a n/a n/a
2022-11-04 2022-09-30 13F VIKING THERAPEUTICS PUT Put 1,700 750.00 4 n/a n/a n/a
2022-08-03 2022-06-30 13F VIKING THERAPEUTICS PUT Put 200 -98.83 0 -100.00 n/a n/a n/a
2022-05-02 2022-03-31 13F VIKING THERAPEUTICS PUT Put 17,100 -45.89 51 -64.83 n/a n/a n/a
2022-02-23 2021-12-31 13F/A VIKING THERAPEUTICS PUT Put 31,600 -21.98 145 -43.36 n/a n/a n/a
2022-02-04 2021-12-31 13F VIKING THERAPEUTICS PUT Put 40,500 256 n/a n/a n/a
2021-10-28 2021-09-30 13F VIKING THERAPEUTICS PUT Put 40,500 0.00 256 5.79 n/a n/a n/a
2021-08-12 2021-06-30 13F VIKING THERAPEUTICS PUT Put 40,500 6,992.82 242 -32.96 n/a n/a n/a
2021-04-26 2021-03-31 13F VIKING THERAPEUTICS PUT Put 571 -36.91 361 -29.08 n/a n/a n/a
2021-02-02 2020-12-31 13F VIKING THERAPEUTICS PUT Put 905 -0.77 509 -3.96 n/a n/a n/a
2020-10-14 2020-09-30 13F VIKING THERAPEUTICS PUT Put 912 -8.43 530 -26.18 n/a n/a n/a
2020-07-13 2020-06-30 13F VIKING THERAPEUTICS PUT Put 996 12.67 718 73.85 n/a n/a n/a
2020-04-29 2020-03-31 13F VIKING THERAPEUTICS PUT Put 884 89.29 413 10.43 n/a n/a n/a
2020-02-05 2019-12-31 13F VIKING THERAPEUTICS PUT Put 467 55.15 374 80.68 n/a n/a n/a
2019-10-15 2019-09-30 13F VIKING THERAPEUTICS PUT Put 301 -40.98 207 -51.06 n/a n/a n/a
2019-07-26 2019-06-30 13F VIKING THERAPEUTICS PUT Put 510 -15.70 423 -29.62 n/a n/a n/a
2019-04-18 2019-03-31 13F VIKING THERAPEUTICS PUT Put 605 56.33 601 103.04 n/a n/a n/a
2019-01-16 2018-12-31 13F VIKING THERAPEUTICS PUT Put 387 -70.77 296 -87.16 n/a n/a n/a
2018-10-23 2018-09-30 13F VIKING THERAPEUTICS PUT Put 1,324 413.18 2,306 845.08 n/a n/a n/a
2018-07-30 2018-06-30 13F VIKING THERAPEUTICS PUT Put 258 1,333.33 244 6,000.00 n/a n/a n/a
2018-04-26 2018-03-31 13F VIKING THERAPEUTICS PUT Put 18 4 n/a n/a n/a
Legend
Shares
The total number of shares held by the institution at the end of the reporting period (the effective date). This is provided in the filing.
Value
The total value of the shares as of the effective date. This is provided in the filing.
Avg. Share Price
The weighted average share price of the shares held by the institution. We use FIFO accounting to determine this price
Class
This is the security class as indicated by the filer. There are a variety of values for this field. Common values include "EC" = equity common, "EP" - equity preferred
Allocation (%)
The percent of the institution's portfolio that this position represents. This is provided in NPORT filings. For 13F filings, we calculate it.
Change in Allocation
The change in allocation from the prior reporting period. This is calculated as current allocation - prior allocation.
Change in Allocation (%)
The percent change in allocation from the prior reporting period. This is calculated as (current allocation - prior allocation) / prior allocation.
Cost Basis
The total cost of the shares held. This is calculated as reported shares * avg. share price
Unrealized Gain/Loss
This is the market value of the position as of the effective date minus the cost basis.